Merck & Co., Inc. (MRK)
Underlying price
$150.15+2.23% today
Stock stats
- Market cap
- $362B
- Previous close
- $146.87
- Open
- $146.78
- Day's range
- $145.60 – $150.49
- 52-week range
- $77.58 – $156.91
- Volume
- 3.84M
- Avg volume
- 10.8M
- P/E ratio
- 114.20
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 53% of the company's 2025 sales were generated from US human health (pharmaceuticals and vaccines).
- Ticker
- MRK
- Asset class
- Equity
- Tokenized by
- 2 issuers
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Employees
- 75,000
- Website
- merck.com
Merck & Co., Inc. FAQ
MRK is Merck & Co., Inc. stock, issued on Solana as a token that tracks the listed share. Each issuer mints its own version, so Merck & Co., Inc. trades here as 2 tokens rather than one.